H1N1疫苗接種損害民事賠償請求案：疫苗製造廠商對受接種者之民事損害賠償責任【學習式判解評析】 試閱
The Damages Claims of H1N1 Vaccination Case: The Liability and Damages of Vaccine Manufacturer
本件原告主張疫苗廠商所生產之H1N1疫苗有瑕疵，致其兒子於施打系爭疫苗後發生死亡之結果，本文就各審之判決理由中，針對疫苗製造廠商，原告可能主張之損害賠償請求權、舉證責任分配原則進行評析，又因為系爭疫苗之產製背景是2009年H1N1新型流感之大流行期間，與自2021年開始之COVID-19疫情侵襲有類似之處，本文同時藉整理此判決之事實以辨明2009年國光H1N1疫苗藥品許可證之合法性，此外，亦一併對藥事管理制度與本件損害賠償請求間之關聯，加以評析。
In present case plaintiffs claimed that the vaccines produced by defendant were defected, then caused their son’s death after vaccination. Here will base on the reasons of judgments to analyze the probable claim rights of plaintiffs and the distribution of the burden of proof. Besides, such vaccines was produced in the period of H1N1 pandemic in 2009. This condition is similar to COVID-19 pandemic outbreak from 2021. So here not only defines the legitimacy of drug permit license of AdimFlu-S (H1N1 vaccine), but commits the relation between pharmacy administration system and damage claims in present case.
058-080
